Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...

Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the ...

Jenna Norton, a vocal critic of Trump administration actions at the NIH, was abruptly placed on administrative leave this ...

Weight loss drugs have skyrocketed in prevalence in recent years, according to a new KFF poll on GLP-1 drugs and drug prices.

Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

There are a few unusual things about the infant botulism outbreak that prompted formula maker ByHeart to recall all of its ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

There are many reasons why a 79-year-old man might need to get an MRI scan of his brain, some benign, some more concerning.

What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...

A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson & Johnson failed in one of three late-stage trials.

Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...